AORT
Price
$23.78
Change
+$0.51 (+2.19%)
Updated
Apr 23 closing price
Capitalization
873.56M
7 days until earnings call
EDAP
Price
$1.63
Change
+$0.16 (+10.88%)
Updated
Apr 23 closing price
Capitalization
281.62M
20 days until earnings call
Ad is loading...

AORT vs EDAP

Header iconAORT vs EDAP Comparison
Open Charts AORT vs EDAPBanner chart's image
Artivion
Price$23.78
Change+$0.51 (+2.19%)
Volume$519.52K
Capitalization873.56M
EDAP TMS SA
Price$1.63
Change+$0.16 (+10.88%)
Volume$81.13K
Capitalization281.62M
AORT vs EDAP Comparison Chart
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. EDAP commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a StrongBuy and EDAP is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AORT: $23.78 vs. EDAP: $1.63)
Brand notoriety: AORT and EDAP are both not notable
AORT represents the Medical Specialties, while EDAP is part of the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AORT: 102% vs. EDAP: 57%
Market capitalization -- AORT: $873.56M vs. EDAP: $281.62M
AORT [@Medical Specialties] is valued at $873.56M. EDAP’s [@Medical Distributors] market capitalization is $281.62M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileEDAP’s FA Score has 0 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • EDAP’s FA Score: 0 green, 5 red.
According to our system of comparison, AORT is a better buy in the long-term than EDAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 6 TA indicator(s) are bullish while EDAP’s TA Score has 6 bullish TA indicator(s).

  • AORT’s TA Score: 6 bullish, 3 bearish.
  • EDAP’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, EDAP is a better buy in the short-term than AORT.

Price Growth

AORT (@Medical Specialties) experienced а +3.03% price change this week, while EDAP (@Medical Distributors) price change was +24.43% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

The average weekly price growth across all stocks in the @Medical Distributors industry was +3.39%. For the same industry, the average monthly price growth was -5.42%, and the average quarterly price growth was -10.98%.

Reported Earning Dates

AORT is expected to report earnings on Jul 31, 2025.

EDAP is expected to report earnings on Aug 20, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical Distributors (+3.39% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AORT($874M) has a higher market cap than EDAP($282M). AORT has higher P/E ratio than EDAP: AORT (434.78) vs EDAP (100.00). AORT YTD gains are higher at: -16.824 vs. EDAP (-26.244). AORT has higher annual earnings (EBITDA): 26.8M vs. EDAP (-18.39M). AORT has more cash in the bank: 58.9M vs. EDAP (43.5M). EDAP has less debt than AORT: EDAP (8.42M) vs AORT (358M). AORT has higher revenues than EDAP: AORT (354M) vs EDAP (60.4M).
AORTEDAPAORT / EDAP
Capitalization874M282M310%
EBITDA26.8M-18.39M-146%
Gain YTD-16.824-26.24464%
P/E Ratio434.78100.00435%
Revenue354M60.4M586%
Total Cash58.9M43.5M135%
Total Debt358M8.42M4,250%
FUNDAMENTALS RATINGS
AORT vs EDAP: Fundamental Ratings
AORT
EDAP
OUTLOOK RATING
1..100
662
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
9194
PRICE GROWTH RATING
1..100
6094
P/E GROWTH RATING
1..100
70100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AORT's Valuation (94) in the Medical Specialties industry is in the same range as EDAP (98) in the Biotechnology industry. This means that AORT’s stock grew similarly to EDAP’s over the last 12 months.

AORT's Profit vs Risk Rating (66) in the Medical Specialties industry is somewhat better than the same rating for EDAP (100) in the Biotechnology industry. This means that AORT’s stock grew somewhat faster than EDAP’s over the last 12 months.

AORT's SMR Rating (91) in the Medical Specialties industry is in the same range as EDAP (94) in the Biotechnology industry. This means that AORT’s stock grew similarly to EDAP’s over the last 12 months.

AORT's Price Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for EDAP (94) in the Biotechnology industry. This means that AORT’s stock grew somewhat faster than EDAP’s over the last 12 months.

AORT's P/E Growth Rating (70) in the Medical Specialties industry is in the same range as EDAP (100) in the Biotechnology industry. This means that AORT’s stock grew similarly to EDAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTEDAP
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENHRX9.940.03
+0.30%
Cullen Enhanced Equity Income Retail
LAAFX17.69N/A
N/A
Lord Abbett Affiliated F
CSCZX43.69N/A
N/A
Columbia Small Cap Value I Inst
BPRRX12.70N/A
N/A
Boston Partners Long/Short Rsrch Inv
IESGX20.94N/A
N/A
Sit ESG Growth I

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with BSX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+2.19%
BSX - AORT
49%
Loosely correlated
+4.07%
MMSI - AORT
49%
Loosely correlated
+2.47%
ITGR - AORT
47%
Loosely correlated
+2.14%
OFIX - AORT
45%
Loosely correlated
+2.13%
IQV - AORT
45%
Loosely correlated
+2.40%
More

EDAP and

Correlation & Price change

A.I.dvisor tells us that EDAP and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
+10.88%
AORT - EDAP
29%
Poorly correlated
+2.19%
ENZ - EDAP
21%
Poorly correlated
N/A
AVNS - EDAP
21%
Poorly correlated
+1.30%
SRDX - EDAP
21%
Poorly correlated
+0.24%
UFPT - EDAP
20%
Poorly correlated
+0.91%
More